Scinovex
articleTop 1% cited

Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction

American Journal of Transplantation · 2005 · Vol. 5(3) · pp. 582–594
Daniel C. BrennanIrfan AghaDaniel L. BohlMark A. SchnitzlerKaren L. HardingerMark B. LockwoodStephanie TorrenceRebecca SchuesslerTiffany RobyMonique Gaudreault‐KeenerGregory A. Storch
Polyomavirus and related diseasesParvovirus B19 Infection StudiesAnimal Virus Infections StudiesImmunosuppressionMedicineViremiaTacrolimusCalcineurinGastroenterologyNephropathyBK virusChronic allograft nephropathyAzathioprine

MeSH terms

BK VirusGraft RejectionHumansImmunosuppressive AgentsRisk FactorsTime FactorsTumor Virus InfectionsViremiaTacrolimusCyclosporinePolyomavirus Infections

Funding

  • National Institutes of Health
Citations
700
FWCI
20.03
field-weighted impact
References
22
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.